Diversity-oriented synthesis of macrocyclic peptidomimetics

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 17, 2011, Pages 6793-6798

  Isidro Llobet, Albert ^a   Murillo, Tiffanie ^a   Bello, Paula ^a   Cilibrizzi, Agostino ^a   Hodgkinson, James T ^a   Galloway, Warren R J D ^a   Bender, Andreas ^a   Welch, Martin ^a   Spring, David R ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Cheminformatics; Macrocycles; Natural products

Indexed keywords

ACID; AZIDE; MACROCYCLIC COMPOUND; MORPHOLINE DERIVATIVE; PEPTIDOMIMETIC AGENT; PIPERAZINEDIONE;

ARTICLE; BIOLOGICAL ACTIVITY; CHEMICAL STRUCTURE; DIVERSITY ORIENTED SYNTHESIS; MOLECULAR LIBRARY; PRIORITY JOURNAL; STRUCTURE ANALYSIS; SYNTHESIS;

MACROCYCLIC COMPOUNDS; MOLECULAR STRUCTURE; PEPTIDOMIMETICS;

EID: 79955562617     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1015267108     Document Type: Article

References (75)

1. Kaiser M, Wetzel S, Kumar K, Waldmann H (2008) Biology-inspired synthesis of compound libraries. Cell Mol Life Sci 65:1186-1201.
2. Spring DR (2005) Chemical genetics to chemical genomics: Small molecules offer big insights. Chem Soc Rev 34:472-482.
3. Kawasumi M, Nghiem P (2007) Chemical genetics: Elucidating biological systems with small-molecule compounds. J Invest Dermatol 127:1577-1584. (Pubitemid 46933419)
4. Spiegel DA, Schroeder FC, Duvall JR, Schreiber SL (2006) An oligomer-based approach to skeletal diversity in small-molecule synthesis. J Am Chem Soc 128:14766-14767. (Pubitemid 44851590)
5. Walsh DP, Chang YT (2006) Chemical genetics. Chem Rev 106:2476-2530.
6. Galloway WRJD, Bender A, Welch M, Spring DR (2009) The discovery of antibacterial agents using diversity-oriented synthesis. Chem Commun 2446-2462.
7. Galloway WRJD, Diaz-Gavilan M, Isidro-Llobet A, Spring DR (2009) Synthesis of unprecedented scaffold diversity. Angew Chem Int Edit 48:1194-1196.
8. Galloway WRJD, Spring DR (2009) Is synthesis the main hurdle for the generation of diversity in compound libraries for screening? Expert Opin Drug Dis 4:467-472.
9. Galloway WRJD, Isidro-Llobet A, Spring DR (2010) Diversity-oriented synthesis as a tool for the discovery of novel biologically active small molecules. Nat Commun 1:80, 10.1038/ncomms1081.
10. Spring DR (2003) Diversity-oriented synthesis; a challenge for synthetic chemists. Org Biomol Chem 1:3867-3870.
11. Haggarty SJ (2005) The principle of complementarity: Chemical versus biological space. Curr Opin Chem Biol 9:296-303.
12. Schwarz MK, Sauer WHB (2003) Molecular shape diversity of combinatorial libraries: A prerequisite for broad bioactivity. J Chem Inf Comput Sci 43:987-1003.
13. Burke MD, Schreiber SL (2004) A planning strategy for diversity-oriented synthesis. Angew Chem Int Edit 43:46-58. (Pubitemid 38063470)
14. Burke MD, Berger EM, Schreiber SL (2003) Generating diverse skeletons of small molecules combinatorially. Science 302:613-618. (Pubitemid 37310911)
15. Schreiber SL (2009) Molecular diversity by design. Nature 457:153-154.
16. Kennedy JP, et al. (2008) Application of combinatorial chemistry science on modern drug discovery. J Comb Chem 10:345-354.
17. Shelat AA, Guy RK (2007) Scaffold composition and biological relevance of screening libraries. Nat Chem Biol 3:442-446. (Pubitemid 47080378)
18. Lovering F, Bikker J, Humblet C (2009) Escape from flatland: Increasing saturation as an approach to improving clinical success. J Med Chem 52:6752-6756.
19. Spandl RJ, Bender A, Spring DR (2008) Diversity-oriented synthesis; a spectrum of approaches and results. Org Biomol Chem 6:1149-1158. (Pubitemid 351432832)
20. Lipinski C, Hopkins A (2004) Navigating chemical space for biology and medicine. Nature 432:855-861. (Pubitemid 40037141)
21. Bender A, et al. (2006) Diversity oriented synthesis: A challenge for synthetic chemists. Chemical Genomics: Small Molecule Probes to Study Cellular Function, eds S Jaroch and H Weinmann (Springer, Berlin), pp 47-60.
22. Hopkins AL, Mason JS, Overington JP (2006) Can we rationally design promiscuous drugs? Curr Opin Struct Biol 16:127-136.
23. Thomas GL, Wyatt EE, Spring DR (2006) Enriching chemical space with diversity-oriented synthesis. Curr Opin Drug Disc Dev 700-712. (Pubitemid 44759564)
24. Clardy J, Walsh C (2004) Lessons from natural molecules. Nature 432:829-837. (Pubitemid 40037138)
25. Pucheault M (2008) Natural products: Chemical instruments to apprehend biological symphony. Org Biomol Chem 6:424-432.
26. Schneider G, Grabowski K (2007) Properties and architecture of drugs and natural products revisited. Curr Chem Biol 1:115-127.
27. Schreiber SL (2000) Target-oriented and diversity-oriented organic synthesis in drug discovery. Science 287:1964-1969.
28. Comer E, Rohan E, Deng L, Porco JA, Jr (2007) An approach to skeletal diversity using functional group pairing of multifunctional scaffolds. Org Lett 9:2123-2126.
29. Di Micco S, et al. (2009) Identification of lead compounds as antagonists of protein Bcl xL with a diversity-oriented multidisciplinary approach. J Med Chem 52:7856-7867.
30. Kuruvilla FG, Shamji AF, Sternson SM, Hergenrother PJ, Schreiber SL (2002) Dissecting glucose signalling with diversity-oriented synthesis and small-molecule microarrays. Nature 416:653-657. (Pubitemid 34406768)
31. Stanton BZ, et al. (2009) A small molecule that binds Hedgehog and blocks its signaling in human cells. Nat Chem Biol 5:154-156.
32. Ng PY, Tang YC, Knosp WM, Stadler HS, Shaw JT (2007) Synthesis of diverse lactam carboxamides leading to the discovery of a new transcription-factor inhibitor. Angew Chem Int Edit 46:5352-5355. (Pubitemid 47067632)
33. Koehler AN, Shamji AF, Schreiber SL (2003) Discovery of an inhibitor of a transcription factor using small molecule microarrays and diversity-oriented synthesis. J Am Chem Soc 125:8420-8421. (Pubitemid 36858396)
34. Wyatt EE, et al. (2008) Identification of an anti-MRSA dihydrofolate reductase inhibitor from a diversity-oriented synthesis. Chem Commun 4962-4964.
35. Thomas GL, et al. (2008) Anti-MRSA agent discovery using diversity-oriented synthesis. Angew Chem Int Edit 47:2808-2812.
36. Dandapani S, Marcaurelle LA (2010) Current strategies for diversity-oriented synthesis. Curr Opin Chem Biol 14:362-370.
37. Payne DJ, Gwynn MN, Holmes DJ, Pompliano DL (2007) Drugs for bad bugs: Confronting the challenges of antibacterial discovery. Nat Rev Drug Discov 6:29-40. (Pubitemid 46020284)
38. Pizzirani D, Kaya T, Clemons PA, Schreiber SL (2010) Stereochemical and skeletal diversity arising from amino propargylic alcohols. Org Lett 12:2822-2825.
39. Schreiber SL (2009) The state of the art of chemical biology. The gap between scientists' aspirations and society's expectations. ChemBioChem 10:16-29.
40. Taylor AM, Schreiber SL (2009) Aziridines as intermediates in diversity-oriented syntheses of alkaloids. Tetrahedron Lett 50:3230-3233.
41. Noren-Muller A, et al. (2006) Discovery of protein phosphatase inhibitor classes by biology-oriented synthesis. Proc Natl Acad Sci USA 103:10606-10611. (Pubitemid 44078024)
42. DeSimone RW, Currie KS, Mitchell SA, Darrow JW, Pippin DA (2004) Privileged structures: Applications in drug discovery. Comb Chem High T Scr 7:473-493. (Pubitemid 39108267)
43. Danishefsky S (2010) On the potential of natural products in the discovery of pharma leads: A case for reassessment. Nat Prod Rep 27:1114-1116.
44. Koch MA, et al. (2005) Charting biologically relevant chemical space: A structural classification of natural products (SCONP). Proc Natl Acad Sci USA 102:17272-17277. (Pubitemid 41740856)
45. Wild CT, Shugars DC, Greenwell TK, McDanal CB, Matthews TJ (1994) Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proc Natl Acad Sci USA 91:9770-9774. (Pubitemid 24311889)
46. Kilby JM, et al. (1998) Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry. Nat Med 4:1302-1307. (Pubitemid 28512112)
47. Horne W, Olsen C, Beierle J, Montero A, Ghadiri M (2009) Probing the bioactive conformation of an archetypal natural product HDAC inhibitor with conformationally homogeneous triazole-modified cyclic tetrapeptides. Angew Chem Int Edit 48:4718-4724.
48. Bock VD, Speijer D, Hiemstra H, van Maarseveen JH (2007) 1,2,3-Triazoles as peptide bond isosteres: Synthesis and biological evaluation of cyclotetrapeptide mimics. Org Biomol Chem 5:971-975.
49. Williams RM, Durham CA (1988) Bicyclomycin: Synthetic, mechanistic, and biological studies. Chem Rev 88:511-540.
50. Campbell J, Blackwell HE (2009) Efficient construction of diketopiperazine macroarrays through a cyclative-cleavage strategy and their evaluation as luminescence inhibitors in the bacterial symbiont Vibrio fischeri. J Comb Chem 11:1094-1099.
51. Hamann MT (2004) Technology evaluation: Kahalalide F (PharmaMar). Curr Opin Mol Ther 6:657-665.
52. Magauer T, Martin H, Mulzer J (2009) Total synthesis of the antibiotic kendomycin by macrocyclization using photo-fries rearrangement and ring-closing metathesis. Angew Chem Int Edit 48:6032-6036.
53. Nahrwold M, Bogner T, Eissler S, Verma S, Sewald N "Clicktophycin- 52": A bioactive cryptophycin-52 triazole analogue. Org Lett 12:1064-1067.
54. Driggers EM, Hale SP, Lee J, Terrett NK (2008) The exploration of macrocycles for drug discovery-An underexploited structural class. Nat Rev Drug Discov 7:608-624. (Pubitemid 351927725)
55. Nielsen T, Schreiber S (2008) Towards the optimal screening collection: A synthesis strategy. Angew Chem Int Edit 47:48-56.
56. Lundquist JT, Pelletier JC (2001) Improved solid-phase peptide synthesis method utilizing α-azide-protected amino acids. Org Lett 3:781-783.
57. Galibert M, Dumy P, Boturyn D (2009) One-pot approach to well-defined biomolecular assemblies by orthogonal chemoselective ligations. Angew Chem Int Edit 48:2576-2579.
58. Looper RE, Pizzirani D, Schreiber SL (2006) Macrocycloadditions leading to conformationally restricted small molecules. Org Lett 8:2063-2066. (Pubitemid 43823611)
59. Bock VD, Perciaccante R, Jansen TP, Hiemstra H, van Maarseveen JH (2006) Click chemistry as a route to cyclic tetrapeptide analogues: Synthesis of cyclo-[Pro-Val-Ψ (triazole)-Pro-Tyr]. Org Lett 8:919-922. (Pubitemid 43411997)
60. Springer J, et al. (2008) Backbone amide linker strategy for the synthesis of 1,4-triazole-containing cyclic tetra- and pentapeptides. Eur J Org Chem 2008:2592-2600.
61. Zhang L, et al. (2005) Ruthenium-catalyzed cycloaddition of alkynes and organic azides. J Am Chem Soc 127:15998-15999. (Pubitemid 41689208)
62. Kelly AR, et al. (2009) Accessing skeletal diversity using catalyst control: Formation of n and n + 1 macrocyclic triazole rings. Org Lett 11:2257-2260.
63. Marcaurelle LA, et al. (2010) An aldol-based build/couple/pair strategy for the synthesis of medium- and large-sized rings: Discovery of macrocyclic histone deacetylase inhibitor. J Am Chem Soc 132:16962-16976.
64. Kolb HC, Finn MG, Sharpless KB (2001) Click chemistry: Diverse chemical function from a few good reactions. Angew Chem Int Edit 40:2004-2021.
65. Huisgen R (1984) 1,3-Dipolar cycloadditions - Introduction, survey, mechanism. 1,3-Dipolar Cycloaddition Chemistry, ed A Padwa (Wiley, New York), Vol 1, pp 1-176.
66. Gisin BF, Merrifield RB (1972) Carboxyl-catalyzed intramolecular aminolysis. A side reaction in solid-phase peptide synthesis. J Am Chem Soc 94:3102-3106.
67. Suzuki K, Sasaki Y, Endo N, Mihara Y (1981) Acetic acid-catalyzed diketopiperazine synthesis. Chem Pharm Bull 29:233-237. (Pubitemid 11131701)
68. Lumley JA (2005) Compound selection and filtering in library design. QSAR Comb Sci 24:1066-1075.
69. Boger DL, Zhou JC (1993) Total synthesis of (+)-piperazinomycin. J Am Chem Soc 115:11426-11433. (Pubitemid 24015713)
70. Ringner M What is principal component analysis? Nat Biotechnol 26:303-304.
71. Bauer RA, DiBlasi CM, Tan DS (2010) The tert-butylsulfinamide lynchpin in transition-metal-mediated multiscaffold library synthesis. Org Lett 12:2084-2087.
72. Wishart DS, et al. (2008) DrugBank: A knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res 36:D901-D906. (Pubitemid 351149842)
73. Irwin JJ, Shoichet BK (2005) ZINC - A free database of commercially available compounds for virtual screening. J Chem Inf Model 45:177-182.
74. Fergus S, Bender A, Spring DR (2005) Assessment of structural diversity in combinatorial synthesis. Curr Opin Chem Biol 9:304-309. (Pubitemid 40804554)
75. Breneman CM, et al. (2003) New developments in PEST shape/property hybrid descriptors. J Comput Aid Mol Des 17:231-240. (Pubitemid 37062784)